QuantLogix's 5-factor engine currently reads Bristol-Myers Squibb Co. (BMY) as a buy at 63/100 — a bullish setup. Options is the strongest leg at 77/100, while momentum lags at 50/100. In backtesting, 46% of 50 comparable historical setups moved higher within five trading days. BMY trades in the Pharmaceutical Preparations sector with a $116.2B market cap.

Live 5-factor quant signal — technical, momentum, fundamental, options, and microstructure — recomputed every few minutes. Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. See the verified track record → · Browse all signal scorecards →